Received Feb 21, 2025
| Type | Name | Manufacturer | Dose | Lot | Route / Site |
|---|---|---|---|---|---|
| MENB | MENINGOCOCCAL B (BEXSERO) | NOVARTIS VACCINES AND DIAGNOSTICS | UNK | — | — |
she received Bexsero when she was 68 years old; This non-serious case was reported by a consumer via call center representative and described the occurrence of inappropriate age at vaccine administration in a 68-year-old female patient who received Men B NVS (Bexsero) for prophylaxis. The patient's past medical history included splenectomy. In AUG-2023, the patient received Bexsero. In AUG-2023, an unknown time after receiving Bexsero, the patient experienced inappropriate age at vaccine administration (Verbatim: she received Bexsero when she was 68 years old). The outcome of the inappropriate age at vaccine administration was unknown. This report is made by GSK without prejudice and does not imply any admission or liability for the incident or its consequences. Additional Information: GSK Receipt Date: 31-JAN-2025 The patient received Bexsero when she was 68 years old which led to inappropriate age at vaccine administration. The patient stated that she received the vaccine as a recommendation from her doctor due to having her spleen removed by surgery.
Medical History/Concurrent Conditions: Splenectomy